Five things for pharma marketers to know: Tuesday, February 7, 2017

Five things for pharma marketers to know: Tuesday, February 7, 2017

Teva CEO steps down; Mylan to pay $96.5 million to settle pay-for-delay claims; Merck files Keytruda with the FDA for bladder cancer

Lawmakers reintroduce bill to include PAs and NPs in Open Payments reporting

Lawmakers reintroduce bill to include PAs and NPs in Open Payments reporting

The bill, if enacted, would publicly share information about industry payments to physician assistants and nurse practitioners.

Five things for pharma marketers to know: Monday, February 6, 2017

Five things for pharma marketers to know: Monday, February 6, 2017

Novo Nordisk CEO describes 'volatile' pricing environment; Lilly to cut 200 research and development jobs; pharma opts out of Super Bowl this year

10 ways healthcare companies are testing Instagram

10 ways healthcare companies are testing Instagram

Pharmaceutical and healthcare companies use a mix of corporate and brand accounts on Instagram, and some are turning to celebrity influencers.

Five things for pharma marketers to know: Friday, February 3, 2017

Five things for pharma marketers to know: Friday, February 3, 2017

Trial finds that Repatha reduces risk of heart attack and stroke; California measure would ban drug coupons in some cases; Takeda to limit price increases

Sales of Keytruda miss analysts' mark

Sales of Keytruda miss analysts' mark

Thirty-percent of Keytruda's U.S. sales came from its lung-cancer indication.

Merck campaign shows impact of shingles

Merck campaign shows impact of shingles

To drive the point home, the ads even feature an image of an actual case of shingles. The blistering red rash appears on-screen for several seconds.

Five things for pharma marketers to know: Thursday, February 2, 2017

Five things for pharma marketers to know: Thursday, February 2, 2017

Biogen completes hemophilia spinoff; old drug being tested as a prostate cancer treatment; Merck reports Q4 decline in revenue

BreathResearch's Nirinjan Yee on being a female entrepreneur

BreathResearch's Nirinjan Yee on being a female entrepreneur

A bout with Lyme disease led Yee to found a company that helps patients measure and track their breathing patterns.

WPP to merge Ogilvy CommonHealth, ghg, Sudler, and CMI into new company

WPP to merge Ogilvy CommonHealth, ghg, Sudler, and CMI into new company

A WPP insider has been tapped as CEO of WPP Health & Wellness, and Ogilvy CommonHealth chairman/CEO Matt Giegerich is stepping down.

Five things for pharma marketers to know: Wednesday, February 1, 2017

Five things for pharma marketers to know: Wednesday, February 1, 2017

Trump wants to speed up drug approvals; Sanofi allergy drug gets OTC approval; Lilly ends final solanezumab trial

MM&M's top 5 stories in January 2017

MM&M's top 5 stories in January 2017

Merck and Aetna partner in value-based drug pricing; data scientists rising in the biopharma ranks; Japanese pharma leads digital health innovation

WPP wins Walgreens account, to create 'Team WBA'

WPP wins Walgreens account, to create 'Team WBA'

WPP will create "Team WBA," a bespoke team that would work on traditional and digital advertising, media, and PR.

The 2017 MM&M Awards is now open for entries

The 2017 MM&M Awards is now open for entries

The annual awards program has added three new categories.

Merck launches DTC campaign for Keytruda

Merck launches DTC campaign for Keytruda

The drugmaker previously launched an unbranded campaign about lung-cancer biomarkers.

Five things for pharma marketers to know: Tuesday, January 31, 2017

Five things for pharma marketers to know: Tuesday, January 31, 2017

Diabetes patients sue drugmakers over price increases; the FTC opens Mylan investigation; Fitbit to ramp up marketing

Five things for pharma marketers to know: Monday, January 30, 2017

Five things for pharma marketers to know: Monday, January 30, 2017

Merck details price increases for its drugs; Trump's call to freeze federal hiring may not affect the FDA; Sanofi to settle vaccines-pricing lawsuit

Five things for pharma marketers to know: Friday January 27, 2017

Five things for pharma marketers to know: Friday January 27, 2017

BMS cuts forecast after Opdivo setbacks; diabetes death rate rises; McKesson acquires prior authorization startup

Infographic: How Trump will affect healthcare marketing budgets

Infographic: How Trump will affect healthcare marketing budgets

A new survey found that 34% of healthcare and pharma marketers say that the election of President Trump will not affect their marketing budgets.

Survey: 26% of brand execs say Trump will affect 2017 marketing budgets

Survey: 26% of brand execs say Trump will affect 2017 marketing budgets

A Haymarket Media survey of more than 700 client-side marcomms execs in the US reveals the shift in power will not significantly affect budgets.

Five things for pharma marketers to know: Thursday, January 26, 2017

Five things for pharma marketers to know: Thursday, January 26, 2017

J&J to buy Actelion for $30 billion; Pfizer fights advertising ban related to Advil; almost half of women with breast cancer report severe side effects

Continuum and Lyft to offer free rides to clinical-trial patients

Continuum and Lyft to offer free rides to clinical-trial patients

Transportation barriers can limit patient involvement in clinical trials.

Patients are increasingly asking docs about drugs in DTC ads: poll

Patients are increasingly asking docs about drugs in DTC ads: poll

Docs said patients asked about drugs from DTC ads six times in a typical week, compared to just twice a week five years ago.

Five things for pharma marketers to know: Wednesday, January 25, 2017

Five things for pharma marketers to know: Wednesday, January 25, 2017

Novartis forecasts slower growth in 2017; Actelion reports trial failure for PAH drug; HHS nominee Tom Price denies conflict of interest claims

Five things for pharma marketers to know: Tuesday, January 24, 2017

Five things for pharma marketers to know: Tuesday, January 24, 2017

Endo settles pay-for-delay charges; Trump signs order withdrawing U.S. from TPP; administration considers Patrick Soon-Shiong for healthcare role

FDA guidance seeks to clarify pharma comms with payers

FDA guidance seeks to clarify pharma comms with payers

But it may also increase the reporting burden for drugmakers.

Five things for pharma marketers to know: Monday, January 23, 2017

Five things for pharma marketers to know: Monday, January 23, 2017

BMS and Ono settle Keytruda patent suit; PhRMA plans to release new campaign; Trump moves forward with plans to scale back the ACA

6 personalization practices from Walgreens' Balance Rewards program

6 personalization practices from Walgreens' Balance Rewards program

How the retail pharmacy chain uses customer data to make its marketing messages relevant.

Healthcare communicators track Obamacare repeal debate

Healthcare communicators track Obamacare repeal debate

Many healthcare comms leaders are paying close attention to the debate between "access" to healthcare versus making it a requirement, experts say.

Five things for pharma marketers to know: Friday, January 20, 2017

Five things for pharma marketers to know: Friday, January 20, 2017

Pharma among top sponsors of Trump inauguration parties; AstraZeneca exec to replace GSK president of global pharmaceuticals; EpiPen rival to relaunch

In draft guidance, the FDA defines appropriate off-label comms as being 'consistent' with the label

In draft guidance, the FDA defines appropriate off-label comms as being 'consistent' with the label

The regulator is providing examples of appropriate off-label communications.

Five things for pharma marketers to know: Thursday, January 19, 2017

Five things for pharma marketers to know: Thursday, January 19, 2017

The FDA releases three documents; PBM rebates eating into drugmaker revenue: PhRMA; most oncologists on Twitter receive money from pharma

Wunderman Health taps former Merkle exec as SVP of strategy and analytics

Wunderman Health taps former Merkle exec as SVP of strategy and analytics

Deborah Furey will lead the agency's pilot of a new personalized marketing offering.

MM&M opens nominations for Hall of Femme

MM&M opens nominations for Hall of Femme

MM&M last year named its inaugural class of 16 Femmes and 20 Women to Watch. Who should be considered for this year's list of breakthough women?

Five things for pharma marketers to know: Wednesday, January 18, 2017

Five things for pharma marketers to know: Wednesday, January 18, 2017

Rep. Price to answer questions at confirmation hearing; 22 drugmakers invest in fighting disease in poor countries; FDA approves generic of Jazz's Xyrem

Industry hires and promotions: January 2017

Industry hires and promotions: January 2017

Endo hires new head of U.S. branded pharma, and three other people moves for you to know about.

The FDA targeted DTC, video, unapproved drug promotion in 2016

The FDA targeted DTC, video, unapproved drug promotion in 2016

The agency issued 11 enforcement letters last year.

Five things for pharma marketers to know: Tuesday, January 17, 2017

Five things for pharma marketers to know: Tuesday, January 17, 2017

Biogen to pay $1.25 billion for patents to MS drugs; Supreme Court to hear Novartis case over Zarxio delay; Merck KGaA inks big-data deal

Five things for pharma marketers to know: Friday, January 13, 2017

Five things for pharma marketers to know: Friday, January 13, 2017

CVS to sell generic EpiPen; FDA finalizes biosimilar naming rules; Pfizer wants to make a deal

GCI Health plants its flag in Philadelphia

GCI Health plants its flag in Philadelphia

The firm is sharing space in the City of Brotherly Love with healthcare media shop CMI.

Day 3 at JP Morgan: The move toward big data requires drugmakers to ask questions

Day 3 at JP Morgan: The move toward big data requires drugmakers to ask questions

There are dozens of players, including leaders like IBM Watson Health and Verily as well as smaller concerns, lining up to sell pharma access to some sort of data solution.

Five things for pharma marketers to know: Thursday, January 12, 2017

Five things for pharma marketers to know: Thursday, January 12, 2017

Trump says pharma is "getting away with murder"; Senate majority votes to repeal ACA; IBM Watson Health and FDA to study blockchain technology

Merck's Keytruda combo could edge out the competition

Merck's Keytruda combo could edge out the competition

Merck said the FDA accepted its submission of a Keytruda/chemotherapy combo drug and granted it Priority Review.

Day 2 at JP Morgan: Change is coming, but which drugmakers will stay on top?

Day 2 at JP Morgan: Change is coming, but which drugmakers will stay on top?

J&J's CEO may be right. Customers of all kinds are demanding change.

Five things for pharma marketers to know: Wednesday, January 11, 2017

Five things for pharma marketers to know: Wednesday, January 11, 2017

The FDA accepts Keytruda combo for review; Valeant offloads Dendreon and skincare brands; pharmacies feeling the squeeze from Express Scripts

Tonic Life promotes Stephanie DeViteri to MD

Tonic Life promotes Stephanie DeViteri to MD

DeViteri started in the newly created role this month.

Physicians group urges metformin rather than new drugs

Physicians group urges metformin rather than new drugs

The American College of Physicians said the costs of some new diabetes drugs do not always mean added benefits for patients.

Day 1 at JP Morgan: Pricing is top of mind for pharma CEOs

Day 1 at JP Morgan: Pricing is top of mind for pharma CEOs

The questions being asked about how drugs are priced are weighing heavily on pharma leaders, and they know the issue is not going away.

Five things for pharma marketers to know: Tuesday, January 10, 2017

Five things for pharma marketers to know: Tuesday, January 10, 2017

Illumina and IBM enter DNA sequencing partnership; J&J to outline price increases in new report; Egalet's opioid Arymo ER gets FDA approval

Ex-Guidemark CEO Matt Brown hangs out new shingle, Brand Mettle

Ex-Guidemark CEO Matt Brown hangs out new shingle, Brand Mettle

The new agency will focus on marketing goods and services to people 50 years of age and older.

MMC's Diana Littman on waiting for a decision after a pitch

MMC's Diana Littman on waiting for a decision after a pitch

She says her experience in consumer brands helps her push healthcare clients to be more creative.

Five things for pharma marketers to know: Monday, January 9, 2017

Five things for pharma marketers to know: Monday, January 9, 2017

Takeda to acquire Ariad for $4.6 billion, Merck pairs with Incyte for Keytruda combo drug collaboration; Sanofi announces autoimmune research deal

Five things for pharma marketers to know: Friday, January 6, 2017

Five things for pharma marketers to know: Friday, January 6, 2017

Judge halts Praluent sales; clinical-trial data for Diclegis in question; cancer drugs to make up larger portion of total drug spending

The FDA to study whether people can recognize misleading drug ads

The FDA to study whether people can recognize misleading drug ads

The agency has faced questions about how it regulates off-label communications.

Five things for pharma marketers to know: Thursday, January 5, 2017

Five things for pharma marketers to know: Thursday, January 5, 2017

Orexigen launches new campaign for weight-loss drug Contrave; Arena sells Belviq to Eisai; Alexion reportedly pushed for 'pull-in' sales

QuintilesIMS taps Staub as head of R&D solutions

QuintilesIMS taps Staub as head of R&D solutions

The merger of Quintiles and IMS Health closed in October.

Five things for pharma marketers to know: Wednesday, January 4, 2017

Five things for pharma marketers to know: Wednesday, January 4, 2017

Sanofi, Regeneron denied bid to overturn Amgen win in patent case; Abbott to close St. Jude deal; Gilead hires SVP of hematology and oncology

The FDA in 2016: By the numbers

The FDA in 2016: By the numbers

With 2016 in the rearview, here are four stats detailing how the FDA fared last year in enforcing regulations and approving new drugs.

How different generations form online "tribes"

How different generations form online "tribes"

Facebook and Instagram are the primary location for brands to engage with online tribes, while Raptr and PlayFire are a hit with boomers.

Five things for pharma marketers to know: Tuesday, January 3, 2017

Five things for pharma marketers to know: Tuesday, January 3, 2017

The FDA approves 22 new drugs in 2016; the Philippines orders Sanofi to stop Dengvaxia ads; new spinal muscular atrophy drug to cost $375,000

Five things for pharma marketers to know: Thursday, December 29, 2016

Five things for pharma marketers to know: Thursday, December 29, 2016

Gilead forms network to encourage access to hep.-C drugs; Dentsu CEO to resign following the suicide of a staffer; BI to divest animal-health products

MM&M's top health technology stories of 2016

MM&M's top health technology stories of 2016

We at MM&M found out just how much pharma marketers love a list. Here, read through the year's most-read technology stories.

Five things for pharma marketers to know: Wednesday, December 28, 2016

Five things for pharma marketers to know: Wednesday, December 28, 2016

Sanofi sues Novo over Tresiba marketing; the FDA issues two more untitled letters; U.S. health spending rose substantially from 1996 to 2013

MM&M's top stories of 2016

MM&M's top stories of 2016

Find out what stories generated the most interest among our readers.

Five things for pharma marketers to know: Tuesday, December 27, 2016

Five things for pharma marketers to know: Tuesday, December 27, 2016

Allergan's board endorses its social contract with patients; drugmakers that market painkillers are hiring DEA officials; the FDA approves new Biogen drug

Luxottica looks to 360 video to highlight childhood vision

Luxottica looks to 360 video to highlight childhood vision

When the vision company needed to demonstrate to parents the plight of children struggling to see, it turned to Olson 1to1 and a 360 video to tell the story.

Five things for pharma marketers to know: Thursday, December 22, 2016

Five things for pharma marketers to know: Thursday, December 22, 2016

Senate report said certain drugmakers act like hedge funds; ViiV to develop HIV prevention drug; lawmakers to replace ACA with "universal access"

Five things for pharma marketers to know: Wednesday, December 21, 2016

Five things for pharma marketers to know: Wednesday, December 21, 2016

GSK's two-drug combo for HIV has positive Phase-III results; the FDA approves glucose system that doesn't use finger pricking; Rite Aid to sell stores

The FDA issues two more enforcement letters this week

The agency has sent nine untitled and warning letters so far this year.

CME providers use Facebook Live to educate doctors

CME providers use Facebook Live to educate doctors

A recent CME course using Facebook Live generated 34,000 views and 600 comments.

Five things for pharma marketers to know: Tuesday, December 20, 2016

Five things for pharma marketers to know: Tuesday, December 20, 2016

Biogen names new CEO; the FDA issues two warning letters; Allergan to acquire aesthetics firm

Drugmakers formalize patient roles as they work to define patient centricity

Drugmakers formalize patient roles as they work to define patient centricity

For years pharma has said it needs to be more focused on patients, has it delivered?

Five things for pharma marketers to know: Monday, December 19, 2016

Five things for pharma marketers to know: Monday, December 19, 2016

The FDA drops Chantix's black-box warning; hospitals try to reduce drug spending; AstraZeneca's head of oncology to depart

The next generation: Q&As with 3 agency staffers

The next generation: Q&As with 3 agency staffers

MM&M conducted Q&As with Stephanie Robinson, senior account manager, The Bloc; Jessica Hill, account supervisor, Ogilvy CommonHealth; and Austin Bald, account executive, TBWA\WorldHealth.

A look back: Q&As with Lester Barnett, C. Marshall Paul, and Steve Girgenti

A look back: Q&As with Lester Barnett, C. Marshall Paul, and Steve Girgenti

Read what they have to say about the defining moments and challenges in their careers.

Millennial staffers at agencies seek work-life balance and strong supervisors

Millennial staffers at agencies seek work-life balance and strong supervisors

Many young staffers agree one of the biggest challenges in their careers has been learning the delicate balance of when to speak up and when to listen.

MM&M launches Young Jurists program

MM&M launches Young Jurists program

We are looking for young professionals who are determined to develop their careers in healthcare advertising and marketing.

Five things for pharma marketers to know: Friday, December 16, 2016

Five things for pharma marketers to know: Friday, December 16, 2016

Allergan to settle allegations relating to speakers bureaus; Mylan launches generic version of the EpiPen; 20 states sue six drugmakers accused of price-fixing

Pfizer creates app for patients with depression

Pfizer creates app for patients with depression

The connection to Pristiq is not overt in the app's user interface, though Moodivator is featured on Pristiq's website.

Five things for pharma marketers to know: Thursday, December 15, 2016

Five things for pharma marketers to know: Thursday, December 15, 2016

Drugmakers promote new type of opioid with unproven results; Heritage execs charged for price-fixing generics; Pershing sells more Valeant shares

The FDA issues untitled letters to Sanofi and Celgene over distracting ads

The FDA issues untitled letters to Sanofi and Celgene over distracting ads

Regulators said the ads distract viewers from superimposed safety information.

The FDA extends deadline for off-label input

The FDA extends deadline for off-label input

The previous deadline was January 9.

Five things for pharma marketers to know: Wednesday, December 14, 2016

Five things for pharma marketers to know: Wednesday, December 14, 2016

Obama signs 21st Century Cures Act into law; the FDA approved 19 new drugs in 2016; Sanofi in talks to acquire Actelion

Eli Lilly will discount its insulins to some patients

Eli Lilly will discount its insulins to some patients

Eli Lilly partnered with Express Scripts to improve adherence for diabetes patients with high-deductible health plans.

Five things for pharma marketers to know: Tuesday, December 13, 2016

Five things for pharma marketers to know: Tuesday, December 13, 2016

Lilly to offer discounts for insulin products; Trump reportedly considering Scott Gottlieb to lead FDA; three execs depart Valeant

Chandler Chicco cofounder launches network of healthcare comms firms

Chandler Chicco cofounder launches network of healthcare comms firms

Bob Chandler retired from his role as cofounder and principal of Chandler Chicco Companies and president of InVentiv Health Communications in 2014.

Biogen recruits Jamie-Lynn Sigler for Tecfidera campaign

Biogen recruits Jamie-Lynn Sigler for Tecfidera campaign

TV actress Jamie Lynn Sigler shares her experience using the multiple-sclerosis drug in the branded campaign.

Five things for pharma marketers to know: Monday, December 12, 2016

Five things for pharma marketers to know: Monday, December 12, 2016

Generic Tamiflu estimated to generate $500 million in savings this year; ADA expected to launch new diabetes treatment guidelines; Alexion CEO resigns

MM&M launches search for 2017 Healthcare Transformers

MM&M launches search for 2017 Healthcare Transformers

It is also seeking industry input for a new category of honoree, the Top 10 Innovation Catalysts.

Merck kicks off lung-cancer campaign

Merck kicks off lung-cancer campaign

On the heels of Keytruda's approval in first-line lung cancer, the drugmaker kicked off an unbranded campaign raising awareness about biomarkers.

Five things for pharma marketers to know: Friday, December 9, 2016

Five things for pharma marketers to know: Friday, December 9, 2016

BMS to pay $19.5 million to settle marketing violations for Abilify; AstraZeneca to cut 700 U.S. jobs; Trump reportedly considering Jim O'Neill to lead FDA

How pharma can stay compliant when using programmatic

How pharma can stay compliant when using programmatic

The risk of fraud is also very real, especially in an industry that already faces privacy and compliance challenges, one expert says.

Five things for pharma marketers to know: Thursday, December 8, 2016

Five things for pharma marketers to know: Thursday, December 8, 2016

A California lawmaker reintroduces drug-pricing bill; France, Poland, Spain, and Sweden lobby to host EMA; drug stocks fall after Trump's comments

An EHR strategy can't be measured in clicks, says Lilly exec

An EHR strategy can't be measured in clicks, says Lilly exec

Pharma can reach physicians within the EHR, but they must send the right message at the right time, she said at an MM&M event.

Spectrum names Jonathan Wilson CEO

Spectrum names Jonathan Wilson CEO

Wilson will succeed founder and CEO John Seng.

W2O Group acquires Sentient Interactive

W2O Group acquires Sentient Interactive

This is W2O Group's third acquisition since a private-equity firm took an investment in May.

Senate passes Cures Act, which opens door to use of real-world evidence

Senate passes Cures Act, which opens door to use of real-world evidence

The bill now heads to President Obama's desk. He is expected to sign the sweeping piece of legislation.

Five things for pharma marketers to know: Wednesday, December 7, 2016

Five things for pharma marketers to know: Wednesday, December 7, 2016

Trump puts pharma on notice over drug prices; Mylan lays off nearly 10% of its workforce; Pfizer slapped with U.K. antitrust fine

GSK and Propeller Health's smart inhaler aims to improve adherence in clinical trials

GSK and Propeller Health's smart inhaler aims to improve adherence in clinical trials

The drugmaker is using Propeller Health's sensor technology to find new ways to improve adherence in clinical studies.

BI and Lilly face a new challenge: how to market a diabetes drug to cardiologists

BI and Lilly face a new challenge: how to market a diabetes drug to cardiologists

Boehringer Ingelheim and Eli Lilly have to position their third-in-class diabetes medication Jardiance as a heart drug.

OPINION

Email Newsletters